A Phase 2 interventional study of Prednisolone and Colchicine in Oral Aphthae, sponsored by Mashhad University of Medical Sciences. Status unknown at 1 site in Iran, Islamic Republic of. Open to participants aged 15 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-07-29.
Sponsored by Mashhad University of Medical Sciences · Phase 2, Interventional, and Treatment
The purpose of this study is to determine whether low doses of prednisolone, or colchicine are effective in the treatment of oral aphthae.
Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. The main goals of therapy are to minimize pain and functional disabilities as well as decrease inflammatory reactions and frequency of recurrences.
61 studies on the registry are indexed under Stomatitis, Aphthous; 16 are open to participants now.
This study's planned enrollment of 30 is below the median of 48 across 53 interventional studies indexed under Stomatitis, Aphthous.
Browse Stomatitis, Aphthous studies →Mashhad University of Medical Sciences is the lead sponsor of 90 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Prednisolone
Drug: Colchicine
5MG Prednisolone per day for 3 months
0.5 MG Colchicine per day for 3 months
frequency of ulcers
Time frame: 1 year
This study is status unknown, as verified in Jul 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mashhad University of Medical Sciences